1611 ET - Altria's current valuation is too high given the company has been offsetting cigarette volume declines through pricing, UBS analysts say in a research note. The maker of Marlboro cigarettes' combination of double digit cigarette volume declines and limited progress in smoke-free means Altria's net income could decline in FY26 and FY27, the analysts say, noting that their EPS estimates are 4.4% and 7.5% below consensus. Overall, the analysts project cigarette shipments to decline 13% in the first quarter, including a 160 basis points share loss that would result in smokeable net sales being down 2.9%. Shares fell 2% to $58.79. (sabela.ojea@wsj.com; @sabelaojeaguix)
(END) Dow Jones Newswires
April 01, 2025 16:11 ET (20:11 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.